These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 22159223)
1. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Chang I; Liu J; Majid S; Saini S; Zaman MS; Yamamura S; Shahryari V; Chiyomaru T; Deng G; Dahiya R; Tanaka Y Carcinogenesis; 2012 Feb; 33(2):420-6. PubMed ID: 22159223 [TBL] [Abstract][Full Text] [Related]
2. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Salih SM; Jamaluddin M; Salama SA; Fadl AA; Nagamani M; Al-Hendy A Fertil Steril; 2008 May; 89(5 Suppl):1414-21. PubMed ID: 17612537 [TBL] [Abstract][Full Text] [Related]
3. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Dawling S; Hachey DL; Roodi N; Parl FF Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160 [TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells. Lehmann L; Jiang L; Wagner J Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686 [TBL] [Abstract][Full Text] [Related]
5. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384 [TBL] [Abstract][Full Text] [Related]
7. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334 [TBL] [Abstract][Full Text] [Related]
8. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635 [TBL] [Abstract][Full Text] [Related]
10. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. Salama SA; Kamel M; Awad M; Nasser AH; Al-Hendy A; Botting S; Arrastia C Int J Cancer; 2008 Sep; 123(6):1246-54. PubMed ID: 18566989 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Tanaka Y; Hirata H; Chen Z; Kikuno N; Kawamoto K; Majid S; Tokizane T; Urakami S; Shiina H; Nakajima K; Dhir R; Dahiya R Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):92-7. PubMed ID: 17220335 [TBL] [Abstract][Full Text] [Related]
12. Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma. Julius JM; Gaikwad A; Lowry A; Lewis RE; Lozano RD; Dalrymple JL; Coleman RL; Smith JA J Antimicrob Chemother; 2012 Feb; 67(2):422-9. PubMed ID: 22129592 [TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542 [TBL] [Abstract][Full Text] [Related]
14. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. Ashburn SP; Han X; Liehr JG Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306 [TBL] [Abstract][Full Text] [Related]
15. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919 [TBL] [Abstract][Full Text] [Related]
16. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice. Zacharia LC; Gogos JA; Karayiorgou M; Jackson EK; Gillespie DG; Barchiesi F; Dubey RK Circulation; 2003 Dec; 108(24):2974-8. PubMed ID: 14662705 [TBL] [Abstract][Full Text] [Related]
17. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma. Shang D; Han T; Xu X; Liu Y Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834 [TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. Al-Hendy A; Salama SA J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190 [TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in renal cell carcinoma by reactive oxygen species: involvement of extracellular signal-regulated kinase 1/2, p38delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor. Ambrose M; Ryan A; O'Sullivan GC; Dunne C; Barry OP Mol Pharmacol; 2006 Jun; 69(6):1879-90. PubMed ID: 16543392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]